
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts

Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
